A venture capital firm founded in 2019 and headquartered in Whitefish, Montana is seeking opportunities across all sectors of life sciences with a focus on biotechnologies, digital health, and infosec. The firm will engage in seed to series B rounds, but mostly looking to invest in series A. A typical allocation can range from 4 – 8 million USD. The firm will invest in companies that are based/headquartered in the US. The firm prefers to lead the investment round and will seek board seats when leading.
The firm is interested in novel technologies that address significant unmet needs in life sciences. The firm is most focused on biotechnologies and digital health but is open to considering all sectors in life sciences. Within the therapeutics sector, the firm is most interested in companies with a diversified pipeline in pre-clinical and clinical trial stages. The firm will consider opportunities in any indication, but has particular interest in oncology, immunology, and neurology. Within the digital health sector, the firm is interested in companies focused on value-based care models and technologies that incorporate machine learning and AI. The firm is also opened to considering medical devices and diagnostics companies of all stages of development. The firm is opportunistic in terms of subsectors and indications in these sectors.
The firm has no strict company or management team requirements, but prefers to work with companies led by founders with strong scientific and technical expertise. The firm does look to take an active role in helping the company to grow.
If you are interested in more information about this investor and other investors tracked by LSN, please email resi@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply